Sertraline plus clonazepam was associated with a significantly greater drop in LSAS severity ( p = 0.020 ) and disability ( p = 0.0028 ) compared with sertraline plus placebo ; no significant differences were observed on these parameters between venlafaxine and either sertraline plus placebo or sertraline plus clonazepam .